)
)
Eton Pharmaceuticals Investor Relations Material
Latest events
Q3 2024
Eton Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Eton Pharmaceuticals Inc
Access all reports
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. Its lead product candidate is Etonogestrel/Ethinyl Estradiol (ETN/EE) Vaginal Contraceptive System (VCS), an FDA approved Class 4 non-biodegradable contraceptive vaginal ring for the treatment of female contraception. The company was founded in 2013 and is based in Bloomingdale, Illinois.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
ETON
Country
🇺🇸 United States